STAGE III LUNG CANCER AJCC V8
Clinical trials for STAGE III LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo shows promise in lung cancer trial
Disease control OngoingThis study tests whether adding the immunotherapy drug atezolizumab to standard chemoradiation improves survival for people with limited stage small cell lung cancer. About 544 participants will receive either chemoradiation alone or chemoradiation plus atezolizumab. The goal is …
Matched conditions: STAGE III LUNG CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 01:35 UTC
-
One-and-Done radiation: new hope for lung cancer patients after surgery?
Disease control OngoingThis study looks at whether a single, precise dose of radiation given after surgery for non-small cell lung cancer is safe and effective. Standard radiation requires many small doses over weeks, which can damage healthy lung tissue. The trial involves 50 adults who had lung cance…
Matched conditions: STAGE III LUNG CANCER AJCC V8
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Apr 29, 2026 01:34 UTC
-
Immunotherapy duo plus radiation shows promise in early lung cancer trial
Disease control OngoingThis early-phase study tested two immunotherapy drugs (ipilimumab and nivolumab) combined with radiation in 21 people with stage II or III non-small cell lung cancer that could not be removed by surgery. The goal was to see if the combination is safe and helps shrink tumors. Part…
Matched conditions: STAGE III LUNG CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 01:34 UTC